Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 6,838	$ 26,342
Total Current Assets	6,838	26,342
Total Assets	6,838	26,342
Current Liabilities
Accounts payable	187,552	196,794
Accrued liabilities	1,322,046	1,141,681
Deferred revenue	31,425	31,425
Notes payable - current	13,942	13,942
Derivative liabilities	1,105,758	951,532
Total Current Liabilities	2,660,723	2,335,374
Due to stockholders	1,000	1,000
Total Liabilities	2,661,723	2,336,374
Commitments and Contingencies (Note 3)
Stockholders' Equity (Deficit)
Common Stock $0.001 Par Value, 10,000,000,000 shares authorized; 586,385,063 shares and 586,285,063 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	586,386	586,286
Additional paid in capital	8,730,313	8,733,193
Accumulated deficit	(13,043,185)	(12,649,512)
Total Stockholders' Equity (Deficit)	(3,726,485)	(3,330,032)
Total Liabilities and Stockholders' Equity (Deficit)	6,838	26,342
Series B Preferred Stock [Member]
Current Liabilities
Temporary equity, value	699,600	699,600
Series C Preferred Stock [Member]
Current Liabilities
Temporary equity, value	68,400	68,400
Series D Preferred Stock [Member]
Current Liabilities
Temporary equity, value	303,600	252,000
Series A Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred stock, value	0	0
Series E Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred stock, value	$ 1	$ 1

No definition available.

Name:	ITOX_DueToStockholders
Namespace Prefix:	ITOX_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).